YK-11 - 100 Tablets
£59.95
In Stock
-
- YK-11 is a synthetic compound classified as a selective androgen receptor modulator (SARM) with a distinctive chemical structure. Unlike typical SARMs, YK-11 is a partial agonist of the androgen receptor and possesses a steroidal backbone, making it a unique subject in the study of muscle growth and bone health. Its structural uniqueness offers a different pathway for interaction with androgen receptors, which has piqued the interest of researchers.
In laboratory settings, YK-11 has been observed to significantly increase the production of follistatin, a protein that acts as a potent myostatin inhibitor. Myostatin is a regulatory protein that limits muscle growth; therefore, inhibiting it can potentially lead to enhanced muscle development. By stimulating follistatin, YK-11 may promote lean muscle mass and strength beyond what is achievable through training and nutrition alone, offering valuable insights into muscle-building mechanisms.
The dual action of YK-11 as both a partial androgen receptor agonist and a myostatin inhibitor sets it apart from other compounds in its category. This unique profile makes it a valuable compound for preclinical research focused on understanding muscle hypertrophy and the regulation of muscle mass. Studies involving YK-11 aim to explore its potential applications in conditions related to muscle wasting and osteoporosis, contributing to the advancement of knowledge in muscle biology and therapeutic development. - The Bottom Line:
YK-11 promotes muscle growth in studies by stimulating follistatin production and inhibiting myostatin. - Box of 100 tablets
- EACH TABLET CONTAINS 5MG OF YK-11
- YK-11 is a synthetic compound classified as a selective androgen receptor modulator (SARM) with a distinctive chemical structure. Unlike typical SARMs, YK-11 is a partial agonist of the androgen receptor and possesses a steroidal backbone, making it a unique subject in the study of muscle growth and bone health. Its structural uniqueness offers a different pathway for interaction with androgen receptors, which has piqued the interest of researchers.